IVF Devices and Consumables Market by Product (Instrument, Accessory & Disposable, and Reagent & Media), Technology (Fresh Embryo IVF, Frozen Embryo IVF, and Donor Egg IVF), and End User (Fertility Clinic, Hospital, Surgical Center, and Clinical Research Institute): Global Opportunity Analysis and Industry Forecast, 2019 - 2026
- Published Date: 2020-10-18
- Report ID: 3478
- Pages: 349
-
Format:
In vitro fertilization is an assisted reproductive technology (ART), which involves retrieving eggs from a womans ovaries and fertilizing them with sperm in vitro. The process involves stimulating a woman's ovulatory, removing an ovum from the woman's ovaries, and allowing the sperm to fertilize in a liquid in a laboratory. IVF is one of the widely used treatments to assist couples with infertility problems. The global IVF devices and consumables market was valued at $2,243 million in 2018, and is projected to reach $7,732 million by 2025, growing at a CAGR of 16.6% from 2019 to 2026.
The global IVF devices & consumables market is anticipated to show significant growth during the forecast period, owing to rise in infertility rate, increase in trend of delayed pregnancies, surge in awareness of IVF, and technological advancements in IVF devices. Furthermore, increase in number of same sex marriages and upsurge in disposable income considerably contribute toward the market growth. However, higher cost, ethical issues and complications associated with IVF hamper the market growth.
The global IVF devices & consumables market is segmented based on product, technology, end user, and region. Based on product, the market is classified into instrument, accessory & disposable, and reagent & media. The instrument segment is further divided into sperm separation system, cryosystem, incubator, imaging system, ovum aspiration pump, cabinet, micromanipulator, and others. Reagent & media is subsegmented into cryopreservation media, semen processing media, ovum processing media, and embryo culture media.
According to technology, the market is categorized into fresh embryo IVF, frozen embryo IVF, and donor egg IVF. Depending on end user, it is divided into fertility clinic, hospital, surgical center, and clinical research institute. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa).
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive IVF devices and consumables market analysis of all the geographical regions is provided to determine the prevailing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product
Instrument
o Sperm Separation System
o Cryosystem
o Incubator
o Imaging System
o Ovum Aspiration Pump
o Cabinet
o Micromanipulator
o Others
Accessory & Disposable
Reagent & Media
o Cryopreservation Media
o Semen Processing Media
o Ovum Processing Media
o Embryo Culture Media
By Technology Type
Fresh Embryo IVF
Frozen Embryo IVF
Donor Egg IVF
By End User
Fertility Clinic
Hospital
Surgical Center
Clinical Research Institute
By Region
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
Asia-Pacific
o Japan
o China
o Australia
o India
o Rest of Asia-Pacific
LAMEA
o Latin America
o Middle East
o Africa
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Cook Medical Inc.
Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.)
Genea Biomedx
Merck KGaA (EMD Serono, Inc.)
Millendo Therapeutics, Inc.
Oxford Gene Technology
Progyny Inc.
The Cooper Companies, Inc. (CooperSurgical, Inc.)
Thermo Fisher Scientific, Inc.
Vitrolife AB
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request).
Esco Micro Pte Ltd.
IVFtech ApS
Chapter: 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
Chapter: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Alternative technologies
3.2.1. Intrauterine insemination (IUI) technique
3.2.1.1. Benefits of IUI
3.2.1.2. Difference between IUI and IVF techniques
3.2.2. Gamete intra-fallopian transfer (GIFT) technique
3.2.2.1. Differences between GIFT and IVF technique
3.2.3. Zygote intrafallopian transfer (ZIFT) technique
3.2.3.1. Differences between ZIFT and IVF technique
3.3. Replacing Ivf Procedures By Fertility Drugs And Surgeries
3.3.1. Female infertility treatments
3.3.2. Risks associated with fertility drugs
3.3.3. Male infertility treatment
3.4. Cost Of IVF Procedures
3.5. Role of Donors In The IVF Market
3.5.1. Egg donation
3.5.2. Egg sharing
3.5.3. Sperm donation
3.5.4. Embryo donation/adoption
3.5.5. Donation for research
3.6. Surrogacy
3.6.1. Legal issues
3.7. IVF Trends In Same Sex Couples
3.7.1. Artificial insemination
3.7.2. Surrogate mothers
3.7.3. In vitro fertilization
3.8. Advanced IVF Technologies
3.8.1. Capsule IVF
3.8.2. Three parent IVF
3.8.2.1. Ethical concerns
3.8.3. Mini IVF
3.8.3.1. Advantages
3.8.3.2. Drawbacks
3.8.4. Embryo scope
3.8.4.1. Advantages
3.8.4.2. PICSI
3.9. Fertility Treatment And Gender Selection
3.9.1. Methods of sex selection
3.9.1.1. Gradient method
3.9.1.2. Flow cytometry technique
3.9.1.3. Pre-implantation genetic diagnosis (PGD)
3.9.1.3.1. Ethical and legal issues
3.10. Metabolomics In Embryo Screening Methods
3.11. Application Of Stem Cells In IVF
3.12. IVF And Resource-Poor Countries
3.13. Key Findings
3.13.1. Top impacting factors
3.13.2. Top investment pockets
3.13.3. Top winning strategies
3.14. Porters Five Forces Analysis
3.14.1. High competition reduces the power of suppliers
3.14.2. Scattered nature and large count of end users regulates the buyer power moderately
3.14.3. High capital cost lowers the threat of new entrants
3.14.4. Industry rivalry is intense due to presence of few dominant competitors
3.14.5. Lack of efficient substitutes lowers the threat from substitutes
3.15. Value Chain Analysis
3.16. Patent Analysis
3.16.1. Patent analysis, by year
3.16.2. Patents analysis, by country
3.17. Regulatory Issues And Legislations
3.18. Insurance Reimbursement Scenario
3.19. Clinical Trial
3.20. Drivers
3.20.1. Delayed pregnancies in women
3.20.2. Increase in global infertility rates
3.20.3. Technological advancement in IVF devices
3.20.4. Increase in gamete donations
3.20.5. Increase in disposable income
3.20.6. Increase in success rates
3.20.7. Surge in healthcare expenditure worldwide
3.21. Restraints
3.21.1. Cost constraints
3.21.2. Complications associated with IVF treatment
3.21.3. Low awareness level
3.22. Opportunities
3.22.1. Fertility tourism
3.22.2. Growth opportunities in the emerging markets
3.22.3. Increase in number of fertility clinics
3.22.4. Rise in same sex marriages
3.23. Impact analyses
Chapter: 4: IVF DEVICES AND CONSUMABLES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Instruments
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by type
4.2.2.1. Sperm separation system
4.2.2.1.1. Market size and forecast
4.2.2.2. Cryosystem
4.2.2.2.1. Market size and forecast
4.2.2.3. Incubator
4.2.2.3.1. Market size and forecast
4.2.2.4. Imaging system
4.2.2.4.1. Market size and forecast
4.2.2.5. Ovum aspiration pump
4.2.2.5.1. Market size and forecast
4.2.2.6. Cabinet (workstation)
4.2.2.6.1. Market size and forecast
4.2.2.7. Micromanipulator system
4.2.2.7.1. Market size and forecast
4.2.2.8. Others
4.2.2.8.1. Market size and forecast
4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country
4.3. Accessories & disposables
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Reagent & media
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by type
4.4.2.1. Cryopreservation media
4.4.3. Different media used in cryopreservation procedures include the following:
4.4.3.1. Market size and forecast
4.4.3.2. Semen processing media
4.4.3.2.1. Market size and forecast
4.4.3.3. Ovum processing media
4.4.3.3.1. Market size and forecast
4.4.3.4. Embryo culture media
4.4.3.4.1. Market size and forecast
4.4.4. Market size and forecast, by region
4.4.5. Market analysis, by country
Chapter: 5: IVF DEVICES AND CONSUMABLES MARKET, BY TECHNOLOGY
5.1. Overview
5.1.1. Market size and forecast
5.2. Fresh Embryo IVF
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Frozen Embryo IVF
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Donor Embryo IVF
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
Chapter: 6: IVF DEVICES AND CONSUMABLES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Fertility Clinics
6.2.1. Market size andforecast
6.2.2. Market analysis, by country
6.3. Hospitals
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Surgical Centers
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Clinical Research Institutes
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
Chapter: 7: IVF DEVICES AND CONSUMABLES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.1.2. IVF devices and consumables market, quarterly update , 2019
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. IVF devices and consumables market, by product
7.2.2.1.2. U.S. IVF devices and consumables market, by technology
7.2.2.1.3. U.S. IVF devices and consumables market, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada IVF devices and consumables market, by product
7.2.2.2.2. Canada IVF devices and consumables market, by technology
7.2.2.2.3. Canada IVF devices and consumables market, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico IVF devices and consumables market, by product
7.2.2.3.2. Mexico IVF devices and consumables market, by technology
7.2.2.3.3. Mexico IVF devices and consumables market, by end user
7.2.3. North America IVF devices and consumables market, by product
7.2.4. North America IVF devices and consumables market, by technology
7.2.5. North America IVF devices and consumables market, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany IVF devices and consumables market, by product
7.3.2.1.2. Germany IVF devices and consumables market, by technology
7.3.2.1.3. Germany IVF devices and consumables market, by end user
7.3.2.2. France
7.3.2.2.1. France IVF devices and consumables market, by product
7.3.2.2.2. France IVF devices and consumables market, by technology
7.3.2.2.3. France IVF devices and consumables market, by end user
7.3.2.3. UK
7.3.2.3.1. UK IVF devices and consumables market, by product
7.3.2.3.2. UK IVF devices and consumables market, by technology
7.3.2.3.3. UK IVF devices and consumables market, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy IVF devices and consumables market, by product
7.3.2.4.2. Italy IVF devices and consumables market, by technology
7.3.2.4.3. Italy IVF devices and consumables market, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain IVF devices and consumables market, by product
7.3.2.5.2. Spain IVF devices and consumables market, by technology
7.3.2.5.3. Spain IVF devices and consumables market, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe IVF devices and consumables market, by product
7.3.2.6.2. Rest of Europe IVF devices and consumables market, by technology
7.3.2.6.3. Rest of Europe IVF devices and consumables market, by end user
7.3.3. Europe IVF devices and consumables market, by product
7.3.4. Europe IVF devices and consumables market, by technology
7.3.5. Europe IVF devices and consumables market, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan IVF devices and consumables market, by product
7.4.2.1.2. Japan IVF devices and consumables market, by technology
7.4.2.1.3. Japan IVF devices and consumables market, by end user
7.4.2.2. China
7.4.2.2.1. China IVF devices and consumables market, by product
7.4.2.2.2. China IVF devices and consumables market, by technology
7.4.2.2.3. China IVF devices and consumables market, by end user
7.4.2.3. Australia
7.4.2.3.1. Australia IVF devices and consumables market, by product
7.4.2.3.2. Australia IVF devices and consumables market, by technology
7.4.2.3.3. Australia IVF devices and consumables market, by end user
7.4.2.4. India
7.4.2.4.1. India IVF devices and consumables market, by product
7.4.2.4.2. India IVF devices and consumables market, by technology
7.4.2.4.3. India IVF devices and consumables market, by end user
7.4.2.5. Rest of Asia-Pacific
7.4.2.5.1. Rest of Asia-Pacific IVF devices and consumables market, by product
7.4.2.5.2. Rest of Asia-Pacific IVF devices and consumables market, by technology
7.4.2.5.3. Rest of Asia-Pacific IVF devices and consumables market, by end user
7.4.3. Asia-Pacific IVF devices and consumables market, by product
7.4.4. Asia-Pacific IVF devices and consumables market, by technology
7.4.5. Asia-Pacific IVF devices and consumables market, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Latin America
7.5.2.1.1. Latin American IVF devices and consumables market, by product
7.5.2.1.2. Latin American IVF devices and consumables market, by technology
7.5.2.1.3. Latin American IVF devices and consumables market, by end user
7.5.2.2. Middle East
7.5.2.2.1. Middle East IVF devices and consumables market, by product
7.5.2.2.2. Middle East IVF devices and consumables market, by technology
7.5.2.2.3. Middle East IVF devices and consumables market, by end user
7.5.2.3. Africa
7.5.2.3.1. Africa IVF devices and consumables market, by product
7.5.2.3.2. Africa IVF devices and consumables market, by technology
7.5.2.3.3. Africa IVF devices and consumables market, by end user
7.5.3. LAMEA IVF devices and consumables market, by product
7.5.4. LAMEA IVF devices and consumables market, by technology
7.5.5. LAMEA IVF devices and consumables market, by end user
Chapter: 8: COMPANY PROFILES
8.1. Cook Medical Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. SWOT analysis
8.2. The Cooper Companies, Inc. (CooperSurgical, Inc.)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.2.7. SWOT analysis
8.3. Merck KGaA (EMD Serono, Inc.)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Product portfolio
8.3.6. Key strategic moves and developments
8.3.7. SWOT analysis
8.4. Genea Biomedx
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Product portfolio
8.4.4. Key strategic moves and developments
8.4.5. SWOT analysis
8.5. Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.5.7. SWOT analysis
8.6. Millendo Therapeutics, Inc.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Key strategic moves and developments
8.6.6. SWOT analysis
8.7. Oxford Gene Technology
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Key strategic moves and developments
8.7.6. SWOT analysis
8.8. Progyny Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.8.5. SWOT analysis
8.9. Thermo Fisher Scientific Inc.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. SWOT analysis
8.10. Vitrolife AB
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
8.10.7. SWOT analysis
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
